Managing side effects is discussed in GLP-1 side effect management guides
References: Cell Metabolism (2024)
One paper reports that for endurance athletes, the literature supports the use of the KD as an effective strategy for reducing body weight and fat mass, suggesting potential improvements in performance at submaximal intensities (60%) [254]
(2024) Semaglutide for the treatment of overweight and obesity: A review, Diabetes, Obesity and Metabolism (2023) Should I consider metformin therapy for weight loss in patients with obesity but without diabetes?, Cleveland Clinic Journal of Medicine (2023) Acute pancreatitis in a patient taking semaglutide, Cureus (2023) Wegovy semaglutide injection, solution, DailyMed (2024) Label: Metformin hydrochloride tablet, DailyMed (2024) Cancer benefits and risks from Ozempic, Wegovy, and other weight loss drugs, Memorial Sloan Kettering Cancer Center (2024) Safety of semaglutide, Frontiers in Endocrinology (2021) Association between metformin and vitamin B12 deficiency in patients with Type 2 diabetes, World Journal of Diabetes (2023) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
doi: 10.1164/AJRCCM.160.1.9807044 105 BarnesPJHanselTT
For a comprehensive look at this topic, our guide on GLP-1 and hair loss covers prevention strategies, supplementation protocols, and when to seek dermatological evaluation
